Tilray Brands Inc
NASDAQ:TLRY

Watchlist Manager
Tilray Brands Inc Logo
Tilray Brands Inc
NASDAQ:TLRY
Watchlist
Price: 1.41 USD -1.4% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Tilray Brands Inc?
Write Note

Relative Value

The Relative Value of one TLRY stock under the Base Case scenario is 2.14 USD. Compared to the current market price of 1.41 USD, Tilray Brands Inc is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TLRY Relative Value
Base Case
2.14 USD
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
53
Median 3Y
2.6
Median 5Y
3.7
Industry
2.5
Forward
1.3
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-4.4
Industry
21.8
Forward
-15.5
vs History
vs Industry
14
Median 3Y
-23.3
Median 5Y
-19.6
Industry
16.1
vs History
vs Industry
7
Median 3Y
-10.4
Median 5Y
-9.7
Industry
23.8
vs History
88
vs Industry
76
Median 3Y
0.5
Median 5Y
0.6
Industry
2.1
vs History
93
vs Industry
48
Median 3Y
2.6
Median 5Y
4.2
Industry
2.7
Forward
1.4
vs History
79
vs Industry
27
Median 3Y
13.2
Median 5Y
13.2
Industry
5.2
vs History
vs Industry
38
Median 3Y
-21.4
Median 5Y
-19.6
Industry
13.5
Forward
18.4
vs History
vs Industry
20
Median 3Y
-9.8
Median 5Y
-9.9
Industry
16.8
Forward
-13.1
vs History
vs Industry
15
Median 3Y
-23.7
Median 5Y
-21.1
Industry
15.2
vs History
vs Industry
8
Median 3Y
-19
Median 5Y
-16.7
Industry
19.3
vs History
87
vs Industry
78
Median 3Y
0.4
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

TLRY Competitors Multiples
Tilray Brands Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Tilray Brands Inc
NASDAQ:TLRY
1.2B USD 1.5 -5.8 -70.9 -8.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
755.8B USD 18.5 90.3 48.5 54.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
351.1B USD 4 23.9 11.6 15.1
US
Merck & Co Inc
NYSE:MRK
251.8B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.5B USD 2.5 35.6 10.6 16
P/S Multiple
Revenue Growth P/S to Growth
US
Tilray Brands Inc
NASDAQ:TLRY
Average P/S: 382 942.1
1.5
38%
0
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
4 211 733
22%
194 879.4
US
Eli Lilly and Co
NYSE:LLY
18.5
109%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
29%
19.9
DK
Novo Nordisk A/S
CSE:NOVO B
10.2
77%
0.1
US
Johnson & Johnson
NYSE:JNJ
4
13%
0.3
US
Merck & Co Inc
NYSE:MRK
4
20%
0.2
CH
Roche Holding AG
SIX:ROG
3.4
15%
0.2
UK
AstraZeneca PLC
LSE:AZN
4.1
35%
0.1
CH
Novartis AG
SIX:NOVN
3.8
17%
0.2
US
Pfizer Inc
NYSE:PFE
2.5
10%
0.3
P/E Multiple
Earnings Growth P/E to Growth
US
Tilray Brands Inc
NASDAQ:TLRY
Average P/E: 32.4
Negative Multiple: -5.8
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.3
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.9
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Tilray Brands Inc
NASDAQ:TLRY
Average EV/EBITDA: 459.6
Negative Multiple: -70.9
309%
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.6
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Tilray Brands Inc
NASDAQ:TLRY
Average EV/EBIT: 2 011.3
Negative Multiple: -8.9
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.1
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15.1
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top